“Do I have to take this pill for the rest of my life?” is one of the questions I hear most often in clinic. Many people with reflux have been taking a PPI for years, sometimes decades, and they have read about the possible side effects. Here is a balanced look at what the evidence shows, and why surgery is an option for the right patient.
What PPIs do well
PPIs switch off the acid pumps in the stomach lining. They heal inflamed esophagus (esophagitis), control heartburn for most people, and protect against complications. For some patients, such as those with Barrett’s esophagus, severe esophagitis or a stricture, long-term PPI use is clearly recommended.1 If your doctor has prescribed one for these reasons, it is doing an important job.
The possible risks of long-term PPI use
Over the past two decades, observational studies have linked long-term PPI use with a range of problems.1 Some are well established; others are uncertain.
Worth monitoring
- Low magnesium
- Low vitamin B12
- Gut infections, including C. difficile
- Rebound acid when the pill is stopped suddenly
Less certain
- Bone fractures
- Kidney disease
- Pneumonia
- Dementia (later studies have not confirmed this)
Usually mild
- Headache
- Diarrhea or constipation
- Bloating or abdominal discomfort
It is important to keep these risks in perspective. An association in an observational study does not prove the pill caused the problem, because people who need long-term PPIs often have other health issues. The best evidence comes from the COMPASS trial, which randomized more than 17,000 people to pantoprazole or placebo for about three years. It found no significant increase in pneumonia, fractures, kidney disease, dementia or death. The one difference was a small increase in gut infections (1.4% vs 1.0%).2
The American Gastroenterological Association’s advice is sensible: take a PPI when there is a clear reason, at the lowest dose that works, and try to reduce or stop it when it is no longer needed.1,3
Why stopping a PPI can be hard
Many people try to stop and find their symptoms come straight back, sometimes worse than before. Part of this is rebound acid: after weeks on a PPI, the stomach temporarily produces extra acid when the drug is stopped. In a trial of healthy volunteers with no reflux, 44% developed heartburn or indigestion after stopping an eight-week course, compared with 15% on placebo.4 This is why PPIs should be tapered under your doctor’s guidance rather than stopped abruptly.
The bigger reason, for people with a hiatus hernia, is that the underlying problem is still there.
What a PPI can’t fix
A PPI makes the stomach contents less acidic. It does not stop them coming up. With a hiatus hernia, the valve at the bottom of the esophagus is displaced and weakened, so food, fluid and bile can still reflux. That is why many patients on PPIs still have regurgitation, a sour taste at night, coughing or hoarseness, or the bloating and difficulty swallowing that come from a larger hernia. You can read more about these symptoms in When does a hiatus hernia actually need surgery?
How surgery can get you off PPIs
A laparoscopic (keyhole) hiatus hernia repair with fundoplication treats the mechanical problem. I bring the stomach back below the diaphragm, close the opening, and wrap the top of the stomach around the lower esophagus to rebuild a one-way valve. The details are in Keyhole hiatal hernia surgery and fundoplication.
- In a Swedish national study of 2,655 patients, 82% did not need long-term reflux medication or further surgery over a median of 5.6 years.5
- In the UK REFLUX trial, only 26% of patients who had surgery were taking a PPI five years later, compared with 82% of those who stayed on medication. The surgical group also had better reflux symptom scores.6
- In the European LOTUS trial, surgery and well-optimized esomeprazole both controlled reflux in most patients at five years (85% and 92%). Surgery achieved this without daily medication.7
Surgery is not risk-free. Early swallowing tightness and bloating are common and usually settle, and hernias can come back, especially very large ones (see Why do hiatus hernias come back?). The possible complications are listed on the risks page.
Who is a good candidate?
- Reflux proven on testing (endoscopy and pH monitoring), not just heartburn that might have another cause.
- A hiatus hernia, especially with regurgitation or obstructive symptoms that a PPI doesn’t control.
- Younger patients facing decades of daily medication, or anyone who would rather not take a PPI long term.
- Symptoms that respond to a PPI usually predict a good result from surgery.
For patients with a BMI of 35 or more, I discuss combining the repair with weight-loss surgery, because weight is one of the strongest drivers of reflux and of recurrence.
Wondering where you stand? Take the reflux self-assessment, read about hiatus hernia surgery, or see my approach in Dr. Irshad’s Take.
Common questions
Is it safe to take a PPI long term?
Does pantoprazole or omeprazole fix a hiatus hernia?
Why do my reflux symptoms get worse when I stop my PPI?
Will I be able to stop my PPI after hiatus hernia surgery?
Is hiatus hernia surgery covered by OHIP?
References
- Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017;152:706–715.
- Moayyedi P, Eikelboom JW, Bosch J, et al. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology. 2019;157:682–691.
- Targownik LE, Fisher DA, Saini SD. AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review. Gastroenterology. 2022;162:1334–1342.
- Reimer C, Søndergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology. 2009;137:80–87.
- Maret-Ouda J, Wahlin K, El-Serag HB, Lagergren J. Association between laparoscopic antireflux surgery and recurrence of gastroesophageal reflux. JAMA. 2017;318:939–946.
- Grant AM, Boachie C, Cotton SC, et al. Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial). Health Technol Assess. 2013;17(22):1–167.
- Galmiche JP, Hatlebakk J, Attwood S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305:1969–1977.
